Application of tirofiban in patients with acute ischemic stroke
10.3760/cma.j.issn.1673-4165.2024.09.008
- VernacularTitle:替罗非班在急性缺血性卒中患者中的应用
- Author:
Li JIANG
1
;
Zhigang LIANG
;
Zhen ZHANG
Author Information
1. 滨州医学院第二临床医学院，烟台 264003
- Keywords:
Ischemic stroke;
Tirofiban;
Platelet aggregation inhibitors;
Thrombolytic therapy;
Endovascular procedures;
Thrombectomy;
Treatment outcome
- From:
International Journal of Cerebrovascular Diseases
2024;32(9):687-693
- CountryChina
- Language:Chinese
-
Abstract:
Tirofiban is a platelet glycoprotein Ⅱb/Ⅲa receptor antagonist that prevents thrombosis by inhibiting the final common pathway of platelet aggregation. At present, there are increasing clinical studies on the application of tirofiban in patients with acute ischemic stroke, but its safety and efficacy are still controversial. This article reviews the application of tirofiban in patients with acute ischemic stroke.
